Pfizer Inc

Pfizer Inc said on Tuesday it expected to generate $15 billion, or about a quarter of its total revenue this year, from the sale of its COVID-19 vaccine that it has developed with German partner BioNTech....

Pfizer Inc has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements. Pfizer’s vaccine, which was shown...

The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc’s drug to treat a form of blood cancer in newly diagnosed patients as a combination therapy. Pfizer plans to launch the drug, Daurismo, in the...

Pfizer Inc said on Monday that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 percent, boosting the prospects of what could be a billion-dollar-a-year...

Allergan Plc on Thursday sued Pfizer Inc to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively marketed an opioid it acquired from...

Pfizer Inc said on Wednesday it would reorganize into three units, separating its consumer healthcare business that the U.S. drugmaker has been trying to sell since last year. The news comes a day after the company...

Biogen said it plans to start mid-stage tests on the drug, which is being developed to treat cognitive impairment associated with schizophrenia. Biogen Inc said on Monday it would buy Pfizer Inc’s experimental treatment for a...

Pfizer’s shares, which traded at a near 16-year high ahead of fourth-quarter results, were down 1.3 percent premarket on Tuesday. Pfizer Inc beat analysts’ estimate for adjusted profit on Tuesday, helped by strong demand for its...

The partnership comes at a time when gene therapy is gaining momentum, after several high profile failures in the late 1990s and early 2000s, with the U.S. Food and Drug Administration recently updating guidance to help...

News Hour: The U.S. Food and Drug Administration (FDA) on Friday approved Pfizer Inc’s drug, Mylotarg, for certain patients with acute myeloid leukemia (AML). The drug was cleared to treat adults with newly diagnosed AML whose...